Alkem Laboratories Limited (NSE:ALKEM)
India · Delayed Price · Currency is INR 5,830.50
-33.00 (-0.56%)
At close: Jan 14, 2026
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 701.07 billion as of January 14, 2026. Its market cap has increased by 8.41% in one year.
Market Cap
701.07B
Enterprise Value
677.75B
Revenue
138.90B
Ranking
n/a
PE Ratio
29.69
Stock Price
5,830.50
Market Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 701.07B, an increase of 324.37%. That is a compound annual growth rate of 15.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 701.07B | 6.48% |
| Dec 31, 2025 | 658.38B | -2.26% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.15T |
| Divi's Laboratories | 1.72T |
| Cipla | 1.17T |
| Apollo Hospitals Enterprise | 1.05T |
| Mankind Pharma | 918.20B |
| Zydus Lifesciences | 906.31B |
| Aurobindo Pharma | 681.22B |
| Fortis Healthcare | 674.40B |